Position in INTS
as of Jun 30, 2025
· filed Aug 12, 2025
Position Value
$0
+$0 QoQ
Shares Held
0
Ownership
0.000%
of shares outstanding
% of Portfolio
—
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2023
9 quarters on record
Position in Biotechnology
Healthcare · as of Jun 30, 2025PROEQUITIES, INC. holds $0 across 563 Biotechnology names. INTS ranks #3 .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RNAZ |
Transcode Therapeutics, Inc.
|
0 | $0 | |
| 2 | DNA |
Ginkgo Bioworks Holdings, Inc.
|
0 | $0 | |
| 3 | INTS |
Intensity Therapeutics, Inc.
This page
|
0 | $0 | |
| 4 | NTRB |
NutriBand Inc.
|
0 | $0 | |
| 5 | CPRX |
Catalyst Pharmaceuticals, Inc.
|
0 | $0 | |
| 6 | MTVA |
MetaVia Inc.
|
0 | $0 | |
| 7 | EVAX |
Evaxion A/S
|
0 | $0 | |
| 8 | AEON |
AEON Biopharma, Inc.
|
0 | $0 |
All Filings in INTS
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2025-06-30 | $0 | 0 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $0 | 0 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $0 | 0 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $0 | 0 | Shares | Sole | 2024-10-10 | |
| 2024-06-30 | $0 | 0 | Shares | Sole | 2024-07-23 | |
| 2024-03-31 | $0 | 0 | Shares | Sole | 2024-05-01 | |
| 2023-12-31 | $0 | 0 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $0 | 0 | Shares | Sole | 2023-10-30 | |
| 2023-06-30 | $0 | 0 | Shares | Sole | 2023-08-10 | |
| No filing history on record for this holder in this stock. | ||||||